Follow us Facebook Icon

UK Secretary of State for International Trade, Liz Truss visits Serum Institute of India

08 February, 2021

UK delegation led by Secretary of State for International Trade, Liz Truss visited the Serum Institute of India...Read more...

Success Story of Cyrus Poonawalla: The man behind India's prestigious Serum Institute of India

05 February, 2021

Cyrus Poonawalla was born in a family that had old ties to India racing circuit, through the family Poonawalla Stud Farms...Read more...

Source: India TV

India to supply 1.1 billion doses of COVID-19 vaccines to UNICEF

03 February, 2021

Today, we are pleased to announce the conclusion of a long-term supply agreement with the Serum Institute of India for the COVID-19 vaccines, to access two vaccine products through technology transfer from AstraZeneca and Novavax...Read more...

Source: The Economic Times

Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine

29 January, 2021

US biotech firm Novavax has said that its Covid-19 vaccine was 89.3% effective in preventing the killer virus in a trial conducted in the United Kingdom...Read more...

Source: LiveMint

South African regulator approves Serum Institute's Covishield days before receiving vaccine

23 January, 2021

Battling the second wave of Covid-19, South Africa is expected to receive a million doses of Covishield by the end of January and another 5 lakh in February of this year...Read more...

Source: India Today

Serum Institute’s Covishield vaccine may be recommended for international use

18 January, 2021

AstraZeneca is engaging with governments, multilateral organisations and other partners around the world for broad and equitable access...Read more...

Source: LiveMint

Covid-19 vaccination drive: After taking the first shot, here's what corona warriors said

16 January, 2021

A sense of joy and excitement was witnessed at vaccination centres across states as Corona Warriors queued up for their first jab...Read more...

Source: IndiaToday

Serum Institute Chief Adar Poonawalla takes Covid Vaccine

16 January, 2021

I wish India & Sri Narendra Modi Ji great success in launching the world’s largest COVID vaccination roll-out...Read more...

Inside Serum Institute - India's Covid Vaccine Hub: NDTV Exclusive

15 January, 2021

NDTV takes you inside Serum Institute of India where the Covishield vaccine is being manufactured.Read more...

Source: NDTV

Price of Covishield fixed at Rs 200 per dose, SII to begin shipping Covid-19 vaccine

11 January, 2021

Pune-based Serum Institute of India also confirmed that it has received a purchase order from the Government of India for 1.1 crore doses of its coronavirus vaccine 'Covishield'...Read more...

Source: The Economic Times

India's Wait Over, Drug Regulator Says Covid Vaccines Cleared '110% Safe'

04 January, 2021

Drug Controller General of India VG Somani said,."We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe".Read more...

Source: The Economic Times

'Covishield' ready to roll out in coming weeks, says Serum Institute's Adar Poonawalla

03 January, 2021

The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.Read more...

Source: The Economic Times

Serum Institute Of India Chairman, Dr. Cyrus Poonawalla's interview with TV 18 on 30 December 2020

30 December, 2020

Serum Institute Of India Chairman & Managing Director, Dr. Cyrus Poonawalla talks to TV 18 regrading the Covid-19: Oxford-AstraZeneca vaccine approved for use in UK.Read more...

Oxford COVID-19 vaccine 95% effective if given 3 months apart, says SII's Adar Poonawalla

29 December, 2020

Serum Institute of India (SII) CEO Adar Poonawalla said on December 28, that the vaccine is likely to get an emergency-use licence from the UK Medicines.Read more...

Source: Business Today

Dr. Harsh Vardhan launches Serum Institute Of India's Pneumococcal Conjugate Vaccine - Pneumosil

29 December, 2020

Union Health Minister Dr. Harsh Vardhan launched India’s first indigenously developed pneumococcal vaccine, 'PNEUMOSIL' manufactured by the Serum Institute of India.Read more...

Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'

28 December, 2020

The vaccine called PNEUMOSIL® will primarily help to fight against pneumococcal pneumonia amongst children and will be availableRead more...

Oxford-SII's 'Covishield' likely to be Indias first COVID vaccine

26 December, 2020

Pune-based SII is to submit an updated safety data of phase 2 and 3 clinical trials in India, immunogenicity data from the clinical trial in the UK and IndiaRead more...

Source: Business Today

First indigenous vaccine against pneumonia developed by Serum Institute to be launched next week

24 December, 2020

According to the sources, the vaccine will be much more affordable than existing ones manufactured by two foreign companiesRead more...

Source: LiveMint

Serum Institute to soon produce ‘Green Vaccine’

17 December, 2020

The world's largest vaccine maker, Serum Institute of India (SII), could soon become the world’s first company to produce a 'Green Vaccine'.Read more...

Source: MSN News

Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days

15 December, 2020

Serum Institute of India has already manufactured 40 million doses of the Oxford-AstraZeneca COVID-19 vaccine.Read more...

Source: MoneyControl

COVID-19 vaccine: Serum Institute to make 10 crore doses each month from next year

11 December, 2020

So far, SII has made 5 crore doses of the Oxford University-AstraZeneca vaccine.Read more...

Source: LiveMint

Vaccine rollout will take two months after licensing, says Serum Institute's Poonawalla

11 December, 2020

The Serum Institute has taken on a vital role as the largest company licensed to manufacture the Oxford University-AstraZeneca coronavirus vaccine.Read more...

Source: CNBC-TV 18

Adar Poonawalla, CEO of Serum Institute, named 'Asian of the Year' with 6 others

05 December, 2020

SII has collaborated with Oxford University and AstraZeneca for making the COVID-19 vaccine.Read more...

Source: The Economic Times

PM Modi impressed with SII facility, wants vaccine out at earliest: Cyrus Poonawalla

28 November, 2020

The Prime Minister interacted with top scientists at Serum Institute of India and sought to know the status of the trials.Read more...

Source: Indian Express

Covid vaccine should be available for public by April 2021: Serum Institute CEO

20 November, 2020

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on thursday said the Oxford Covid-19 vaccine shoud be available.Read more...

Source: Times of India

SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020

19 November, 2020

The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion of the Covid-19 pandemic.Read more...

COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India

11 November, 2020

The strategic alliance between the SII and the ICMR will advance India’s role in the global race to develop COVID-19 vaccines.Read more...

No safety concerns related to the Covishield vaccine trial: Serum chief

05 November, 2020

Adar Poonawalla, CEO of SII said preliminary results have shown that there are no immediate concerns pertaining to the Covishield vaccine.Read more...

Source: The Indian Express

Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax

03 November, 2020

In a major development, India and Brazil have secured the rights to buy enough quantities of COVID-19 vaccine.Read more...

Source: Swarajya

Adar Poonawalla speaks to NDTV about the coronavirus vaccine and it's development

28 October, 2020

Adar Poonawalla, CEO of Serum Institute of India in an exclusive interview with NDTV's Vishnu Som.Read more...

Coronavirus Vaccine shot painless say Covishield trial volunteers

12 October, 2020

The trial involves 1,600 volunteers in 17 cities across the country.Read more...

Source: The Hindu

Serum Institute Of India Takes A Multipronged Approach In Quest To Produce Worlds First Covid-19 Vaccines

07 October, 2020

When the coronavirus pandemic broke out earlier this year, Adar Poonawalla, CEO of Serum Institute of India, the world’s largest vaccine maker by number of doses produced and sold, weighed the options.Read more...

Source: Forbes


29 September, 2020

The announcement takesforward the collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.Read more...

Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19

23 September, 2020

Vaccine Update from the World’s Largest Vaccine Manufacturer Adar Poonawalla the CEO of Serum Institute of India joins Julia Chatterley to discuss the latest developments in their COVID-19 vaccine.Read more...

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

22 September, 2020

Serum Institute has received necessary regulatory approval from the Review Committee on Genetic Manipulation (RCGM) of India's Department of Biotechnology (DBT) for manufacturing Codagenix's COVID-19 vaccine candidate...Read more...

Source: MoneyControl

Oxford COVID-19 vaccine: Serum Institute to start final phase of trial in India from Monday

19 September, 2020

The phase III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week, said Dr Muralidhar Tambe, Dean of Sassoon General Hospital...Read more...

Source: liveMint

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19

18 September, 2020

US drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually...Read more...

Source: liveMint

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19

16 September, 2020

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID – 19 - Co Hosted by the Johns Hopkins India Institute...Read more...

Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses

15 September, 2020

As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate...Read more...

Source: liveMint

Oxford vaccine trial pause won't have impact on Indian trials: Serum Institute CEO

13 September, 2020

The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants...Read more...

Source: India Today

Looking forward to the Oxford covid vaccine: Serum Institute CEO

08 September, 2020

The Oxford University-AstraZeneca covid vaccine is now undergoing Phase III clinical trials in Britain, Brazil, South Africa and India...Read more...

Source: liveMint


29 August, 2020

The deal announced by the Bangladeshi generic drugmaker comes after Dhaka said this month it was ready to hold trials of candidate vaccines being developed by India as both countries seek to curb the spread of the virus...Read more...

Source: liveMint


The Johns Hopkins University, Baltimore, USA has awaeded its highest honour to Dr. Cyrus Poonawalla...Read more...


26 August, 2020

The 'Covishield' vaccine's trials begin with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune...Read more...

Source: livemint


20 August, 2020

Country’s apex biomedical research agency is also helping Zydus Cadila for laboratory assays to detect antibody response, according to documents reviewed by Mint...Read more...

Source: livemint


19 August, 2020

A total of 1,600 candidates will take part in the study. King Edward Memorial Hospital Parel, and BYL Nair Hospitals, Mumbai Central — have received approval from ICMR to start the trial...Read more...

Source: livemint


18 August, 2020

Serum Institute of India (SII) will begin the phase 2 clinical trials of a promising coronavirus vaccine developed by the University of Oxford this week...Read more...

Source: Times Now News


18 August, 2020

​​The company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccine candidates, ET has learnt...Read more...

Source: The Economic Times


11 August, 2020

The Serum Institute of India is preparing to crank out a billion doses. And that's just the beginning...Read more...

Source: Bloomberg


10 August, 2020

SII is part of the agreement with AstraZeneca, which along with Oxford University has developed a vaccine that has reported satisfactory progress from the test results...Read more...

Source: News18

Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

07 August, 2020

New landmark collaboration between the Serum Institute of India (SII), Gavi, and Bill & Melinda Gates Foundation...Read more...

Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

06 August, 2020

On Tuesday, Novavax reported that its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus in a small...Read more...

Source: The Indian Express

Serum Institute of India gets approval to start human trials for Oxford vaccine

01 August, 2020

Earlier this week, a committee of experts had deferred a decision on the request of SII to start trials and asked the company to amend its protocol for the clinical study...Read more...

Source: The Economic Times

Serum Institute conducting phase III clinical trial of BCG vaccine: DBT

27 July, 2020

About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine...Read more...

Source: MoneyControl

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

22 July, 2020

Adar Poonawalla said if the vaccine trials go fine and the results are favourable, Serum Institute of India will be manufacturing this Covid-19 vaccine as a partner with Oxford University. Read more...

Source: IndiaToday

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

21 July, 2020

SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca. Read more...

Source: News18

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

18 July, 2020

Serum Institute CEO Adar Poonawalla speaks to The Indian Express about their efforts to develop Covid-19 vaccines Read more...

Source: The Indian Express

First Fully Indigenous Pneumonia Vaccine, Developed By Serum Institute, Approved

15 July, 2020

New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune. Read more...

Source: LiveMint

Serum Institute of India expects COVID vaccine by year-end

8 July, 2020

He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate lab processes from sample handling to preparing RT-PCR tubes Read more...

Source: ExpressPharma

serum institute of india to supply pneumonia vaccine to low income nations

17 June, 2020

Pneumonia is the biggest single killer of children, claiming the life of a child every 39 secondsRead more...

Source: LiveMint


10 June, 2020

Our manufacturing facility is ready and we plan to start production in two months. We are spending more than USD 100 million for this facilityRead more...

Source: ET HealthWorld


05 June, 2020

The Pune-based company has executed the deal through its German subsidiary mPower GmbH.Read more...

Source: MoneyControl


04 June, 2020

World leaders make historic commitments to provide equal access to vaccines for all Read more...

Source: Gavi


05 June, 2020

The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine. Read more...

Source: University of Oxford


05 June, 2020

AstraZeneca is the latest deal that Pune-based Serum Institute has stitched together. How did the 50-year-old vaccine maker become the face of the Indian fight against COVID-19? Read more...

Source: MoneyControl


04 June, 2020

The British drug maker also reached a $750m agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and Gavi to support the manufacturing, procurement Read more...

Source: The Economic Times


04 June, 2020

Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic.Read more...

Source: Forbes India


28 May, 2020

Serum Institute has currently joined hands with various global pharmaceutical institutes and firms in efforts to produce a vaccine for Covid-19 Read more...

Source: Hindustan Times


28 April, 2020

In this episode of To The Point, RSTV Speaks to Adar Poonawalla, CEO and Owner, Serum Institute of India. As the world races to find a cure for the deadly novel coronavirus, Read more...


06 April, 2020

With Indian authorities expediting approvals, a viable Coronavirus vaccine may be commercially available earlier than anticipated. Read more...

Source: Fotune India


02 April, 2020

As governments race to get a handle on the spread of the coronavirus and cure the affected people, the medical community has been busy workingRead more...

Source: CNBC TV18


02 April, 2020

Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd has partnered with Serum Institute of India’s CEO Adar Poonawalla and Abhijit Pawar,Read more...

Source: HealthWorld | Economic Times


01 April, 2020

Serum Institute of India has partnered with American biotechnology firm @Codagenix to develop a vaccine against COVID-19, and expects it to be ready by early 2022. Read more...


12 March, 2020

Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company. Read more...



10 March, 2020

Cyrus Poonawalla's Serum Institute has signed a joint venture with US company Codagenix to work on a coronavirus cure Read more...

Source: The Telegraph


07 March, 2020

Serum Institute of India, world’s largest vaccine producer by number of doses produced, headquartered in Pune, has stated that the vaccine for COVID-19 will not be readied before 2022. Read more...

Source: NEWS18 India


19 December, 2019

This milestone marks a key step toward improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low- and middle-income countries. Read more...

Source: Path


16 December, 2019

Serum Institute of India and Villoo Poonawalla Foundation have collaborated with the Camp Education Society to upgrade the infrastructure of two schools. Read more...

Source: India Today


17 November, 2019

Dr. Cyrus Poonawalla was conferred with the Indian Council of Medical Research (ICMR) 'Lifetime Achievement Medal' for his outstanding contribution Read more...



06 November, 2019

Dr. Cyrus Poonawalla was conferred with the 'Lifetime Achievement Award’ by the Asian Business Leadership Forum (ABLF) at the awards ceremony held on 6th November 2019 in Dubai Read more...

Source: Sakal Newspaper


09 September, 2019

Serum Institute of India's new plant inaugurated by Hon'ble Union Health Minister Dr. Harsh Vardhan. Read more...


26 June, 2019

Dr. Cyrus Poonawalla was conferred with the prestigious 'Degree of Doctor of Science, honoris causa' by the University of Oxford, U.K. at a glittering ceremony Read more...


10 December, 2018

Dr Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi. Read more...


7 April, 2018

Mr Adar Poonawalla, CEO, Serum Institute of India, receiving the prestigious Read more...


November, 2017

Adar Poonawalla, CEO of Serum Institute received the Outsatanding achievement in Business & CSR from CNN-News18's Indian of the Year Read more...


8 September, 2017

Prime Minister Narendra Modi’s recent nomination of Pune industrialist Adar Poonawalla, as ambassador for the Swachh Bharat mission, comes in recognition of his major initiative towards a cleaner and greener Pune. Read more...


15 November, 2016

Adar Poonawalla's clean city initiative launched in collaboration with the Pune Municipal Corporation this January has struck a chord with Prime Minister Narendra Modi Read more...


13 November, 2016

Hon'ble Prime Minister Shri. Narendra Modi visited the Serum Institute of India on Sunday 13th November and met with the Chairman & Managing Director Dr. Cyrus Poonawalla and CEO Mr. Adar Poonawalla. Read more...


8 January, 2016

Rem With an aim to make Puce 100 per cent garbage free by the end of 2016, the Poonawalla Group's Serum Institute of India has collaborated with the Pune Municipal Corporation (PMC) Read more...